Bio-Path Holdings, Inc. (BPTH) — 8-K Filings

8-K Filings (41)

• Bio-Path Holdings Announces Executive and Director Changes — Nov 14, 2025 Risk: medium
  Bio-Path Holdings, Inc. announced on November 4, 2025, changes in its executive and director positions. The company filed an 8-K report detailing the departure
• Bio-Path Holdings Appoints New Director, Discloses Executive Compensation — Oct 29, 2025 Risk: low
  Bio-Path Holdings, Inc. announced on October 22, 2025, a change in its board of directors. Specifically, Dr. Robert L. Smith has been appointed as a new directo
• Bio-Path Holdings Appoints New Auditor — Aug 13, 2025 Risk: medium
  Bio-Path Holdings, Inc. filed an 8-K on August 13, 2025, to report changes in its certifying accountant. The company has appointed BDO USA, LLP as its new indep
• Bio-Path Holdings Announces Director Changes and New CFO — Jun 24, 2025 Risk: medium
  Bio-Path Holdings, Inc. announced on June 20, 2025, a series of significant corporate actions. These include the departure of Director Dr. Michael W. R. Smith,
• BIO-PATH HOLDINGS, INC. Files 8-K Report — May 2, 2025 Risk: low
  On May 1, 2025, BIO-PATH HOLDINGS, INC. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no speci
• Bio-Path Holdings Files 8-K: Agreements & Financial Obligations — Apr 29, 2025 Risk: medium
  On April 28, 2025, Bio-Path Holdings, Inc. entered into a material definitive agreement and incurred a direct financial obligation. The company also reported on
• Bio-Path Holdings Files 8-K on Agreements and Equity Sales — Mar 28, 2025 Risk: medium
  On March 28, 2025, BIO-PATH HOLDINGS, INC. filed an 8-K report detailing several key events. These include entering into a material definitive agreement, creati
• Bio-Path Holdings Files 8-K on Financials — Mar 28, 2025 Risk: low
  Bio-Path Holdings, Inc. filed an 8-K on March 28, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhi
• Bio-Path Holdings Files 8-K — Mar 19, 2025 Risk: low
  Bio-Path Holdings, Inc. filed an 8-K on March 19, 2025, reporting an event on March 18, 2025. The filing is a current report under Regulation FD and includes fi
• Bio-Path Holdings Files 8-K: Material Agreement & Financial Obligations — Mar 7, 2025 Risk: medium
  On March 6, 2025, BIO-PATH HOLDINGS, INC. entered into a material definitive agreement and incurred a direct financial obligation. The company also reported on
• Bio-Path Holdings Faces Listing Rule Concerns — Feb 18, 2025 Risk: high
  Bio-Path Holdings, Inc. filed an 8-K on February 18, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filin
• Bio-Path Holdings Files 8-K — Jan 10, 2025 Risk: low
  Bio-Path Holdings, Inc. filed an 8-K on January 10, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, incorporated
• BIO-PATH HOLDINGS, INC. Files 8-K — Dec 19, 2024 Risk: low
  On December 19, 2024, BIO-PATH HOLDINGS, INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and includes Financial Statements and
• Bio-Path Holdings Faces Delisting, Reports Director Changes — Dec 13, 2024 Risk: high
  Bio-Path Holdings, Inc. filed an 8-K on December 13, 2024, reporting a notice of delisting or failure to meet continued listing rules. The filing also covers th
• Bio-Path Holdings Files 8-K — Dec 12, 2024 Risk: low
  Bio-Path Holdings, Inc. filed an 8-K on December 12, 2024, reporting an event on December 11, 2024. The filing is a current report under Regulation FD and inclu
• Bio-Path Holdings Merges with Exegenesis Bio, Inc. — Nov 25, 2024 Risk: medium
  On November 19, 2024, Bio-Path Holdings, Inc. filed an 8-K report detailing the closing of its previously announced merger with Exegenesis Bio, Inc. The merger
• Bio-Path Holdings Files 8-K on Financials — Nov 15, 2024 Risk: low
  Bio-Path Holdings, Inc. filed an 8-K on November 15, 2024, reporting on its results of operations and financial condition, and including financial statements an
• Bio-Path Holdings Enters Material Definitive Agreement — Oct 11, 2024 Risk: medium
  On October 8, 2024, BIO-PATH HOLDINGS, INC. entered into a material definitive agreement, likely related to the unregistered sale of equity securities. The comp
• Bio-Path Holdings Faces Delisting Concerns — Sep 13, 2024 Risk: high
  Bio-Path Holdings, Inc. filed an 8-K on September 13, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The comp
• Bio-Path Holdings Files 8-K — Aug 21, 2024 Risk: low
  Bio-Path Holdings, Inc. filed an 8-K on August 21, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain
• Bio-Path Holdings Files 8-K on Financials — Aug 15, 2024 Risk: low
  Bio-Path Holdings, Inc. filed an 8-K on August 15, 2024, reporting on its results of operations and financial condition. The filing also includes financial stat
• Bio-Path Holdings Files 8-K — Jul 11, 2024 Risk: low
  Bio-Path Holdings, Inc. filed an 8-K on July 11, 2024, reporting an event that occurred on July 8, 2024. The filing indicates "Other Events" and includes "Finan
• Bio-Path Holdings Files 8-K — Jun 14, 2024 Risk: low
  Bio-Path Holdings, Inc. filed an 8-K on June 14, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain s
• Bio-Path Holdings Enters Definitive Agreement, Discloses Equity Sales — Jun 5, 2024 Risk: medium
  Bio-Path Holdings, Inc. announced on June 3, 2024, that it entered into a material definitive agreement. The company also disclosed unregistered sales of equity
• BIO-PATH HOLDINGS, INC. Files 8-K — Jun 3, 2024 Risk: low
  On June 3, 2024, BIO-PATH HOLDINGS, INC. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no spec
• Bio-Path Holdings Files 8-K — May 30, 2024 Risk: low
  Bio-Path Holdings, Inc. filed an 8-K on May 30, 2024, reporting an event on May 23, 2024. The filing is a current report under Regulation FD and includes financ
• Bio-Path Holdings Files 8-K on Operations and Financials — May 15, 2024 Risk: low
  Bio-Path Holdings, Inc. filed an 8-K on May 15, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibi
• Bio-Path Holdings Raises $2M in Stock Sale — Apr 19, 2024 Risk: medium
  On April 18, 2024, Bio-Path Holdings, Inc. entered into a Material Definitive Agreement, specifically a Securities Purchase Agreement, with accredited investors
• BIO-PATH HOLDINGS, INC. Files 8-K Report — Apr 18, 2024 Risk: low
  On April 18, 2024, BIO-PATH HOLDINGS, INC. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating
• Bio-Path Holdings Files 8-K — Apr 15, 2024 Risk: low
  Bio-Path Holdings, Inc. filed an 8-K on April 15, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific d
• Bio-Path Holdings Files 8-K: Material Agreement — Apr 4, 2024 Risk: medium
  On April 4, 2024, Bio-Path Holdings, Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes financial statements and exhib
• Bio-Path Holdings Files 8-K — Apr 2, 2024 Risk: low
  Bio-Path Holdings, Inc. filed an 8-K on April 2, 2024, to report information under Regulation FD and to file financial statements and exhibits. The filing does
• Bio-Path Holdings Files 8-K Report — Mar 27, 2024 Risk: low
  On March 27, 2024, Bio-Path Holdings, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating
• Bio-Path Holdings Raises $1.5M in Preferred Stock Sale — Mar 26, 2024 Risk: medium
  On March 25, 2024, Bio-Path Holdings, Inc. entered into a Material Definitive Agreement, specifically a Securities Purchase Agreement, with accredited investors
• Bio-Path Holdings Faces Nasdaq Delisting Warning — Mar 13, 2024 Risk: high
  Bio-Path Holdings, Inc. (BPTH) filed an 8-K on March 13, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company is fa
• Bio-Path Holdings Raises $2.4M in Direct Offering — Mar 11, 2024 Risk: medium
  Bio-Path Holdings, Inc. announced on March 8, 2024, that it has entered into a securities purchase agreement with an institutional investor for a registered dir
• Bio-Path Holdings Files 8-K on Operations and Financials — Mar 8, 2024 Risk: low
  Bio-Path Holdings, Inc. filed an 8-K on March 8, 2024, reporting on its results of operations and financial condition, as well as presenting financial statement
• BIO-PATH Holdings Amends Bylaws, Modifies Security Holder Rights — Feb 23, 2024 Risk: medium
  BIO-PATH HOLDINGS, INC. filed an 8-K on February 23, 2024, reporting an event that occurred on February 21, 2024. The filing indicates material modifications to
• BIO-PATH HOLDINGS 8-K: Shareholder Vote Matters Reported — Feb 2, 2024
  BIO-PATH HOLDINGS, INC. (BPTH) filed an 8-K on February 2, 2024, reporting an event that occurred on January 30, 2024, related to the submission of matters to a
• BIO-PATH Holdings 8-K: Shareholder Vote Matters Filed Jan 22 — Jan 23, 2024
  BIO-PATH HOLDINGS, INC. (BPTH) filed an 8-K on January 23, 2024, reporting an event that occurred on January 22, 2024, related to the submission of matters to a
• BIO-PATH HOLDINGS Files Routine 8-K, Confirms Nasdaq Listing — Jan 10, 2024
  BIO-PATH HOLDINGS INC filed an 8-K on January 10, 2024, primarily to disclose general corporate information and confirm its registration on The Nasdaq Capital M

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX